Skip to main content

Synnovation Therapeutics

Wilmington, United States

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

$102.0M raised
Dec 2023
Series A

Top Investors

Cormorant Asset ManagementLilly Asia VenturesThird Rock VenturesNextech InvestSirona Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Synnovation Therapeutics

How much funding has Synnovation Therapeutics raised?
Synnovation Therapeutics has raised $102.0M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Who are Synnovation Therapeutics's investors?
Synnovation Therapeutics's investors include Cormorant Asset Management, Lilly Asia Ventures, Third Rock Ventures, Nextech Invest, Sirona Capital.
Where is Synnovation Therapeutics headquartered?
Synnovation Therapeutics is headquartered in Wilmington, United States.
What does Synnovation Therapeutics do?
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
What stage is Synnovation Therapeutics at?
Synnovation Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Synnovation Therapeutics — Funding & Investors." VCBacked, December 14, 2023, https://www.vcbacked.co/company/synnovation-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Synnovation Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/synnovation-therapeutics
Wikipedia (cite web)
{{cite web |title=Synnovation Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synnovation-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .